Literature DB >> 25720694

MiR-212-3p inhibits glioblastoma cell proliferation by targeting SGK3.

Huailei Liu1, Chenguang Li, Chen Shen, Fei Yin, Kaikai Wang, Yaohua Liu, Bingjie Zheng, Weiguang Zhang, Xu Hou, Xin Chen, Jianing Wu, Xiaoxiong Wang, Chen Zhong, Jiakang Zhang, Huaizhang Shi, Jing Ai, Shiguang Zhao.   

Abstract

Glioblastoma multiforme (GBM) is the most malignant brain tumor in humans. Previous studies have demonstrated that microRNA plays important roles in the development and proliferation of GBM cells. Here we defined the mechanism by which miR-212-3p regulated the proliferation of GBM. In this study, we showed that miR-212-3p expression was significantly down-regulated and negatively correlated with serum and glucocorticoid-inducible kinase 3 (SGK3) in GBM. Either over-expression of miR-212-3p or silence of SGK3 decreased viability of GBM cells. Moreover, miR-212-3p directly bound to 3'UTR of SGK3 and inhibited its mRNA and protein expression. And over-expression of SGK3 rescued the decreased proliferation of GBM cells induced by miR-212-3p. Importantly, miR-212-3p also suppressed tumor growth in vivo. Collectively, our results demonstrated that miR-212-3p inhibited proliferation of GBM cells by directly targeting SGK3, and could potentially serve as a new therapeutic target for GBM.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25720694     DOI: 10.1007/s11060-015-1736-y

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  37 in total

1.  Harmine hydrochloride inhibits Akt phosphorylation and depletes the pool of cancer stem-like cells of glioblastoma.

Authors:  Huailei Liu; Dayong Han; Yaohua Liu; Xu Hou; Jianing Wu; Huadong Li; Jie Yang; Chen Shen; Guang Yang; Changyu Fu; Xianfeng Li; Hui Che; Jing Ai; Shiguang Zhao
Journal:  J Neurooncol       Date:  2013-02-08       Impact factor: 4.130

2.  Characterization of sgk, a novel member of the serine/threonine protein kinase gene family which is transcriptionally induced by glucocorticoids and serum.

Authors:  M K Webster; L Goya; Y Ge; A C Maiyar; G L Firestone
Journal:  Mol Cell Biol       Date:  1993-04       Impact factor: 4.272

3.  MiR-106a is an independent prognostic marker in patients with glioblastoma.

Authors:  Shiguang Zhao; Guang Yang; Yulong Mu; Dayong Han; Chen Shi; Xin Chen; Yifan Deng; Daming Zhang; Lu Wang; Yaohua Liu; Xu Hou; Chunlei Wang; Jianing Wu; Huailei Liu; Ligang Wang; Guang Zhang; Jiping Qi; Xiang Fang; Changbin Shi; Jing Ai
Journal:  Neuro Oncol       Date:  2013-02-14       Impact factor: 12.300

4.  SGK3 is an estrogen-inducible kinase promoting estrogen-mediated survival of breast cancer cells.

Authors:  Yuanzhong Wang; Dujin Zhou; Sheryl Phung; Selma Masri; David Smith; Shiuan Chen
Journal:  Mol Endocrinol       Date:  2010-11-17

5.  miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor.

Authors:  Jong-Kook Park; Jon C Henry; Jinmai Jiang; Christine Esau; Yuriy Gusev; Megan R Lerner; Russell G Postier; Daniel J Brackett; Thomas D Schmittgen
Journal:  Biochem Biophys Res Commun       Date:  2011-02-15       Impact factor: 3.575

Review 6.  Serum and glucocorticoid-regulated protein kinases: variations on a theme.

Authors:  Maude Tessier; James R Woodgett
Journal:  J Cell Biochem       Date:  2006-08-15       Impact factor: 4.429

7.  Targeted disruption of the protein kinase SGK3/CISK impairs postnatal hair follicle development.

Authors:  James A McCormick; Yuxi Feng; Kevin Dawson; Martin J Behne; Benjamin Yu; Jian Wang; Amanda W Wyatt; Guido Henke; Florian Grahammer; Theodora M Mauro; Florian Lang; David Pearce
Journal:  Mol Biol Cell       Date:  2004-07-07       Impact factor: 4.138

8.  Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells.

Authors:  Zhizhong Li; Shideng Bao; Qiulian Wu; Hui Wang; Christine Eyler; Sith Sathornsumetee; Qing Shi; Yiting Cao; Justin Lathia; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cancer Cell       Date:  2009-06-02       Impact factor: 31.743

Review 9.  Role of Akt in human malignant glioma: from oncogenesis to tumor aggressiveness.

Authors:  Emmanuel Chautard; Zangbéwendé Guy Ouédraogo; Julian Biau; Pierre Verrelle
Journal:  J Neurooncol       Date:  2014-01-30       Impact factor: 4.130

10.  MiR-29c inhibits glioma cell proliferation, migration, invasion and angiogenesis.

Authors:  Yue-chao Fan; Peng-jin Mei; Chen Chen; Fa-an Miao; Hui Zhang; Zhong-lin Li
Journal:  J Neurooncol       Date:  2013-08-13       Impact factor: 4.130

View more
  19 in total

1.  MiR-212-3p inhibits cell proliferation and promotes apoptosis by targeting nuclear factor IA in bladder cancer.

Authors:  Xiaoming Wu; Hao Chen; Gaoyue Zhang; Jianhui Wu; Wei Zhu; Yanqin Gu; Y I He
Journal:  J Biosci       Date:  2019-09       Impact factor: 1.826

2.  MicroRNA-212 negatively regulates starvation induced autophagy in prostate cancer cells by inhibiting SIRT1 and is a modulator of angiogenesis and cellular senescence.

Authors:  Malathi Ramalinga; Arpita Roy; Anvesha Srivastava; Asmita Bhattarai; Varsha Harish; Simeng Suy; Sean Collins; Deepak Kumar
Journal:  Oncotarget       Date:  2015-10-27

3.  The biological functions and mechanism of miR‑212 in prostate cancer proliferation, migration and invasion via targeting Engrailed-2.

Authors:  Yi Zhou; Zhigang Ji; Weigang Yan; Zhien Zhou; Hanzhong Li
Journal:  Oncol Rep       Date:  2017-07-12       Impact factor: 3.906

4.  MicroRNA‑518b functions as a tumor suppressor in glioblastoma by targeting PDGFRB.

Authors:  Xiaolong Xu; Fenglin Zhang; Xianzhen Chen; Qi Ying
Journal:  Mol Med Rep       Date:  2017-08-21       Impact factor: 2.952

5.  Knockdown of USF1 Inhibits the Vasculogenic Mimicry of Glioma Cells via Stimulating SNHG16/miR-212-3p and linc00667/miR-429 Axis.

Authors:  Di Wang; Jian Zheng; Xiaobai Liu; Yixue Xue; Libo Liu; Jun Ma; Qianru He; Zhen Li; Heng Cai; Yunhui Liu
Journal:  Mol Ther Nucleic Acids       Date:  2019-01-15       Impact factor: 8.886

Review 6.  The functions and targets of miR-212 as a potential biomarker of cancer diagnosis and therapy.

Authors:  Wenjun Chen; Jing Song; Hongjun Bian; Xia Yang; Xiaoyu Xie; Qiang Zhu; Chengyong Qin; Jianni Qi
Journal:  J Cell Mol Med       Date:  2020-01-13       Impact factor: 5.310

7.  ZLM-7 inhibits the occurrence and angiogenesis of breast cancer through miR-212-3p/Sp1/VEGFA signal axis.

Authors:  Xuan Li; Zi-Zheng Zou; Min Wen; Yuan-Zhu Xie; Kun-Jian Peng; Tiao Luo; Su-You Liu; Qin Gu; Ji-Jia Li; Zhi-Yong Luo
Journal:  Mol Med       Date:  2020-11-13       Impact factor: 6.354

8.  Network analysis of microRNA and mRNA seasonal dynamics in a highly plastic sensorimotor neural circuit.

Authors:  Tracy A Larson; Karin L Lent; Theo K Bammler; James W MacDonald; William E Wood; Melissa L Caras; Nivretta M Thatra; Agata Budzillo; David J Perkel; Eliot A Brenowitz
Journal:  BMC Genomics       Date:  2015-11-06       Impact factor: 3.969

9.  LncRNA SNHG5 promotes the progression of osteosarcoma by sponging the miR-212-3p/SGK3 axis.

Authors:  Cheng Ju; Ruihao Zhou; Jun Sun; Feifei Zhang; Xiaofeng Tang; Kaddie Kwok Chen; Junliang Zhao; Xiaoyong Lan; Shifan Lin; Zhiping Zhang; Xiao-Bin Lv
Journal:  Cancer Cell Int       Date:  2018-09-18       Impact factor: 5.722

10.  Characterization of a five-microRNA signature as a prognostic biomarker for esophageal squamous cell carcinoma.

Authors:  Jun Yu; Ming Zhu; Min Lv; Xiaoliu Wu; Xiaomei Zhang; Yuanying Zhang; Jintian Li; Qin Zhang
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.